Navigation Links
Nektar Announces Closing of Sale of Specific Pulmonary Delivery Assets to Novartis for $115 Million
Date:12/31/2008

SAN CARLOS, Calif., Dec. 31 /PRNewswire-FirstCall/ -- Nektar Therapeutics (Nasdaq: NKTR) today announced that it has successfully closed the divestiture of specific Nektar pulmonary delivery assets, technology, and intellectual property to Novartis for $115 million in cash. The transaction was completed on December 31, 2008.

With the closing, Novartis assumes ownership of certain dry powder and liquid pulmonary formulation and manufacturing assets, including capital equipment and manufacturing facility lease obligations. The sale also transferred to Novartis approximately 140 Nektar personnel, as well as certain intellectual property and manufacturing methods, including manufacturing and royalty rights to Novartis' Tobramycin inhalation powder (TIP) program.

Nektar continues to own its Bayer HealthCare-partnered program NKTR-061 (Amikacin Inhale) and royalties from the Ciprofloxacin inhaled powder program (CIP), also partnered with Bayer HealthCare. In addition, Nektar retains its NKTR-063 (inhaled vancomycin) program, as well as all intellectual property specific to inhaled insulin.

JPMorgan acted as exclusive financial advisor to Nektar.

About Nektar

Nektar Therapeutics is a biopharmaceutical company developing novel therapeutics based on its advanced polymer conjugate technology platforms. Nektar's technology and drug development expertise have enabled nine approved products for partners, which include leading biopharmaceutical companies. Nektar is also developing a robust pipeline of its own high-value therapeutics that addresses unmet medical needs by leveraging and expanding its technology platforms to improve and enable molecules. For more information on Nektar Therapeutics, please visit http://www.nektar.com.


'/>"/>
SOURCE Nektar Therapeutics
Copyright©2008 PR Newswire.
All rights reserved

Page: 1 2

Related biology technology :

1. Nektar Therapeutics to Webcast R&D Day on November 12th
2. Nektar Sells Pulmonary Business to Novartis For $115 Million and Nektar Retains Key Pulmonary Programs Including Amikacin Inhale, Inhaled Vancomycin, and Ciprofloxacin Inhalation Powder
3. Nektar Therapeutics President and CEO Howard W. Robin to Present at Natixis Bleichroeder Second Annual Hidden Gems Conference in New York City
4. Nektar Therapeutics President and CEO, Howard W. Robin, to Present at UBS 2008 Global Life Sciences Conference in New York City
5. Nektar to Announce Financial Results for the Second Quarter of 2008 on Wednesday, August 6, 2008, After Close of U.S.-Based Financial Markets
6. Bharatt Chowrira Joins Nektar Therapeutics as Chief Operating Officer and Head of PEGylation Business Unit
7. Nektars PEGylation Technology Enables Peptide Mimetic, Highlighted by Data Presented at 45th ERA-EDTA Congress
8. Nektar Receives Patent Covering Pulmonary Targeted Antibiotics
9. Nektar to Announce Q1 2008 Financial Results on Wednesday, May 7, 2008, After Close of U.S.-Based Financial Markets
10. West Concludes Agreement with Nektar
11. Nektar Announces Restructuring to Complete Its Transition to a Therapeutics Drug Development Organization
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:4/24/2015)... and Tempe, AZ (PRWEB) April 24, 2015 ... and Arizona State University (ASU) have entered into an ... projects. , A memorandum of agreement signed by the ... distance learning, student success and other services particularly, though ... , “We have complementary strengths and a similar ...
(Date:4/24/2015)... , April 24, 2015 /CNW Telbec/ - Mirego, leader ... of the making of three mobile app extensions for the ... for its clients, Familiprix, OMSignal and MediaMiser, these extensions ... thanks to functions designed specifically for wrist use.  ... Apple Watch is a highly customizable tactile smartwatch that makes ...
(Date:4/23/2015)... Diego, CA (PRWEB) April 23, 2015 ... and personal development of executive women in San Diego’s ... of the 17th Annual Pinnacle Awards at their Gala ... Grand Hyatt Hotel. Register now at http://athenasd.org/events/ ... who support the Athena San Diego vision of fostering ...
(Date:4/23/2015)... -- Neurocrine Biosciences, Inc. (Nasdaq: NBIX ) announced today ... results before the Nasdaq market opens on Thursday, April ... and webcast to discuss its financial results and provide ... 8:00 a.m. Eastern Time (5:00 a.m. Pacific Time). ... dialing 866-952-1906 (US) or 785-424-1825 (International) using the conference ...
Breaking Biology Technology:South Dakota Mines, Arizona State University Pave Way for Cooperative Research 2Familiprix, OMSignal and MediaMiser apps available today for Apple Watch 2Athena Pinnacle Awards to Honor Executives, Corporations and Educators Working to Promote Women Leaders 2Neurocrine Biosciences Announces Conference Call and Webcast to Report First Quarter 2015 Results 2
... , , PHILADELPHIA, July ... the Year, today announces the opening of two key new locations in ... 2010 growth plan. Digitas Health has experienced increased annual revenue growth of ... client brand wins over the past 12 months, and has received substantial ...
... , , EMERYVILLE, Calif., ... ) ( http://www.novabaypharma.com ), a clinical stage company developing non-antibiotic ... range of bacterial, viral and fungal infections, announced today that ... at the Jesup & Lamont 2009 Growth Stock Conference organized ...
... GAITHERSBURG, Md., July 27 Today GenVec, Inc. (Nasdaq: ... with the PATH Malaria Vaccine Initiative (MVI) to support the ... funding. This contract, valued at approximately $2 million, will continue ... preclinical feasibility studies of novel adenovirus-based vaccines. Based on the ...
Cached Biology Technology:Digitas Health Expands Adding Two Key Locations 2Digitas Health Expands Adding Two Key Locations 3Digitas Health Expands Adding Two Key Locations 4NovaBay(R) Pharmaceuticals to Present at Jesup & Lamont 2009 Growth Stock Conference 2NovaBay(R) Pharmaceuticals to Present at Jesup & Lamont 2009 Growth Stock Conference 3GenVec Expands Contract Supporting Malaria Vaccine Program 2GenVec Expands Contract Supporting Malaria Vaccine Program 3
(Date:3/31/2015)... 2015  Elephant Talk Communications Corp. (NYSE MKT: ETAK) ... Software Defined Network Architecture (ET Software DNA® 2.0) platforms ... approximately $20.4 million for the year ended December 31, ... the year ended December 31, 2013. ... completed its multi-year transition away from its legacy landline ...
(Date:3/30/2015)... DUBLIN , Mar. 26, 2015 Research and ... addition of the "Global Gesture Recognition Market in ... The analysts forecast the Global Gesture Recognition market ... 12.8% over the period 2013-2018. Gesture recognition ... respond to different gestures of an individual. Gesture recognition ...
(Date:3/24/2015)... Mar. 24, 2015 Research and Markets ... "Global Iris Recognition Market 2015-2019" report to ... Iris Recognition market to grow at a CAGR of ... report covers the present scenario and the growth prospects ... 2015-2019. To calculate the market size, the report considers ...
Breaking Biology News(10 mins):Elephant Talk Reports 2014 Fourth Quarter and Year End Financial Results 2Elephant Talk Reports 2014 Fourth Quarter and Year End Financial Results 3Elephant Talk Reports 2014 Fourth Quarter and Year End Financial Results 4Elephant Talk Reports 2014 Fourth Quarter and Year End Financial Results 5Elephant Talk Reports 2014 Fourth Quarter and Year End Financial Results 6Global Gesture Recognition Market in Automotive Sector Report 2015 - Growing Number of Partnerships 2Global Iris Recognition Market 2015-2019 with 3M Cogent, Bioenable Technologies, Cross Match Technology, Iris ID Systems & Safran Dominating 2
... Counterfeiting of drugs is a huge industry with an ... the situation is extremely serious. Half of the malaria medication ... Lund and the UK have now developed a technique that ... researchers hope to have a prototype ready. It will resemble ...
... species for understanding the condition of specific ecosystems. Their ... health, but lizards are seldom weighed, perhaps due in ... when lizards are in stress. Now ecological researchers ... Shai Meiri of Tel Aviv University,s Department of Zoology ...
... What constitutes ,Britishness, is turning out to be ... multidisciplinary research programme led by the University of Leicester ... The University is to receive a 1.37 ... over five years, to carry out a major study ...
Cached Biology News:Problem of fake medicines in developing countries could be solved 2Getting a tail up on conservation? 2Roots of the British come under new scrutiny 2Roots of the British come under new scrutiny 3Roots of the British come under new scrutiny 4
... The MetaVue Imaging System is the ... With commands tailored to common research ... photography, morphometric analysis and simple image analysis. ... device control library means that MetaVue has ...
Imject Freund's Incomplete Adjuvant (FIA)...
Sterile, Cell culture tested...
... XL extends the MSn performance of the ... tools to generate extensive structural information for ... , Multiple dissociation techniques (PQD, ETD, ... unpredicted metabolites , Fast polarity switching for ...
Biology Products: